fever/hemorrhage

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to synthetic soil extract substances comprising phenolic polymers, and to compositions and methods for employing the synthetic phenolic polymers for preventing, reducing, treating, or eliminating hemorrhagic fever viral

FIELD OF THE INVENTION This application relates generally to the field of viral disease, prophylaxis, and vaccination. More specifically, it provides a virus vaccine modeled on the etiologic agent for Crimean-Congo hemorrhagic fever. It was produced by reducing the deubiquinating and deISGylating

REFERENCE TO A "SEQUENCE LISTING," A TABLE, OR A COMPUTER PROGRAM LISTING APPENDIX SUBMITTED AS AN ASCII TEXT FILE The Sequence Listing written in file U.S. Pat. No. 934,365_ST25.TXT, created on Jul. 7, 2014, 108,900 bytes, machine format IBM-PC, MS-Windows operating system, is hereby incorporated

FIELD OF THE INVENTION The present invention relates to a dengue hemorrhagic fever virus vaccine and compositions thereof and methods of developing the vaccine, to generate an immunity against infection by dengue hemorrhagic fever viruses. The following discussion of the background of the invention

This application is a National Stage Application of PCT/GB2013/053174, filed 29 Nov. 2013, which claims benefit of Serial No. 1303406.1, filed 26 Feb. 2013 in Great Britain and which applications are incorporated herein by reference. To the extent appropriate, a claim of priority is made to each of

FIELD OF THE INVENTION The present invention relates generally to the field of genetic identification and quantification of viruses in the Filoviridae, Flaviviridae, Bunyaviridae and Arenaviridae families and provides methods, compositions and kits useful for this purpose, as well as others, when

INTRODUCTION The present Dengue disease is caused by infection with dengue virus (DV), an arthropod-borne virus transmitted by mosquitoes. Dengue virus is classified in the Flaviviridae family, genus Flavivirus. DV has been subdivided into 4 serotypes, DEN-1. DEN-2, DEN-3, and DEN-4. Dengue virus is

BACKGROUND OF THE INVENTION The invention relates to a vaccine for hemorrhagic fever with renal syndrome caused by hantavirus infections. The Hantavirus genus of the family Bunyaviridae includes a number of rodent-borne viruses that can cause hemorrhagic fever with renal syndrome (HFRS) or

BACKGROUND OF THE INVENTION The invention relates to a vaccine for hemorrhagic fever with renal syndrome caused by hantavirus infections. The Hantavirus genus of the family Bunyaviridae includes a number of rodent-borne viruses that can cause hemorrhagic fever with renal syndrome (HFRS) or

BACKGROUND OF THE INVENTION The invention relates to a vaccine for hemorrhagic fever with renal syndrome caused by hantavirus infections. The Hantavirus genus of the family Bunyaviridae includes a number of rodent-borne viruses that can cause hemorrhagic fever with renal syndrome (HFRS) or

FIELD OF THE INVENTION The present invention relates to the use of sulfonyl semicarbazides, semicarbazides and ureas, as well as derivatives and analogs thereof, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated

FIELD OF THE INVENTION The present invention relates to the use of sulfonyl semicarbazides, semicarbazides and ureas, as well as derivatives and analogs thereof, and pharmaceutical compositions containing the same, for the treatment or prophylaxis of viral infections and diseases associated

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Jan. 21, 2011, is named 56441024.txt and is 9,154 bytes in size. FIELD The use of sulfonyl

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 9, 2011, is named 5644102.txt and is 9,265 bytes in size. FIELD OF THE INVENTION The

SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Oct. 12, 2011, is named 56441026.txt and is 7,802 bytes in size. FIELD The use of sulfonyl